Page 3 - விஸ் மூத்தவர் ஊழியர்கள் விஞ்ஞானி பவன் மகிழ்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விஸ் மூத்தவர் ஊழியர்கள் விஞ்ஞானி பவன் மகிழ்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விஸ் மூத்தவர் ஊழியர்கள் விஞ்ஞானி பவன் மகிழ்ச்சி Today - Breaking & Trending Today

Harvard's Wyss Institute collaborates with GBS Inc. on the Wyss' eRapid-based COVID-19 diagnostic to help curb the pandemic


Share this article
Share this article
BOSTON, Feb. 17, 2021 /PRNewswire/  The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute s eRapid technology with the company s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.
The Wyss Institute collaborates with GBS Inc., a subsidiary of The iQ Group Global, to combine its electrochemical eRapid sensing technology with GBS’s transistor technology in developing a multiplexed COVID-19 biomarker diagnostic. Credit: Wyss Institute at Harvard University ....

Boston University , United States , University Of Massachusetts Medical School , Massachusetts Institute Of Technology , Harvard University , Tufts University , Spaulding Rehabilitation Hospital , George Syrmalis , Pawan Jolly , Paul Dastoor , James Gorman , Donald Ingber , Benjamin Boettner , Gemma Garkut , Beth Israel Deaconess Medical Center , Wyss Institute , Harvard Johna Paulson School Of Engineering , University Of Zurich , Iq Group Global , School Of Mathematical , Farber Cancer Institute , Arts Sciences , Harvard University Office Of Technology Development , Wyss Institute Bioinspired Therapeutics , Sciences Engineering Accelerator , University Of Newcastle ,

Harvard's Wyss Institute collaborates with GBS Inc. on eRapid-based COVID-19 diagnostic


 E-Mail
IMAGE: The Wyss Institute collaborates with GBS Inc., a subsidiary of The iQ Group Global, to combine its electrochemical eRapid sensing technology with the GBS s transistor technology in developing a multiplexed.
view more 
Credit: Wyss Institute at Harvard University
(BOSTON) The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute s eRapid technology with the company s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications. ....

Boston University , United States , University Of Massachusetts Medical School , Massachusetts Institute Of Technology , Harvard University , Dana Farber Cancer Institute , Tufts University , Spaulding Rehabilitation Hospital , George Syrmalis , Pawan Jolly , Paul Dastoor , James Gorman , Donald Ingber , Benjamin Boettner , Gemma Garkut , Beth Israel Deaconess Medical Center , Wyss Institute , Harvard Office Of Technology Development , Harvard Johna Paulson School Of Engineering , University Of Zurich , Iq Group Global , School Of Mathematical , Arts Sciences , Technology Access Framework , Harvard University Office Of Technology Development , Wyss Institute Bioinspired Therapeutics ,

Detecting multiple sepsis biomarkers from whole blood - made fast, accurate, and cheap


 E-Mail
IMAGE: Wyss Institute researchers have developed eRapid technology as an affinity-based, low-cost electrochemical diagnostic sensor platform for the multiplexed detection of clinically relevant sepsis biomarkers in whole blood.
view more 
Credit: Wyss Institute at Harvard University
(BOSTON) Many life-threatening medical conditions, such as sepsis, which is triggered by blood-borne pathogens, cannot be detected accurately and quickly enough to initiate the right course of treatment. In patients that have been infected by an unknown pathogen and progress to overt sepsis, every additional hour that an effective antibiotic cannot be administered significantly increases the mortality rate, so time is of utmost essence. ....

Boston University , United States , University Of Massachusetts Medical School , Massachusetts Institute Of Technology , United Kingdom , Dana Farber Cancer Institute , Tufts University , Spaulding Rehabilitation Hospital , Despina Moschou , Pawan Jolly , Pedro Estrela , Donald Ingber , Benjamin Boettner , Beth Israel Deaconess Medical Center , Arts Sciences , Harvard Wyss Institute For Biologically Inspired Engineering , Wyss Institute , University Of Bath , Defense Advanced Research Projects Agency , Wyss Institute Bioinspired Therapeutics , Us Army Research Office , Centre For Biosensors , University Of Zurich , Biologically Inspired Engineering , Wyss Founding Director Donald Ingber , Wyss Senior Staff Scientist Pawan Jolly ,